Cell and Gene Therapy 01/06/2018 How do you Solve a Problem Like Cell Therapy Manufacturing? The Automation SIG is a platform to debate, collaborate and work towards genuine solutions for the new paradigm of manufacturing needed to ensure commercial viability of advanced therapies.
Cell and Gene Therapy 30/05/2018 Cell and Gene Therapy Manufacturing Capacities in North America Phacilitate's annual cell and gene therapy manufacturing capacities review reaches North America. Brought to you in partnership with Aldevron.
Cell and Gene Therapy 23/05/2018 VIDEO: The Small Biotech's Guide to Managing Partnerships The small biotech's guide to identifying, setting up and successfully managing partnerships with Susan Nichols, CEO Falcon Therapeutics
Cell and Gene Therapy 16/05/2018 Has Japan’s Regenerative Medicine Experiment Paid Off? The first episode in Phacilitate:Exchange's Top Tips series is brought to you by Lee Buckler, President and CEO of...
Cell and Gene Therapy 03/05/2018 VIDEO: Automation is Nothing Without Collaboration This collaborative panel, filmed at Phacilitate Leaders World 2018 in Miami, reviews the 2017 Automation SIG. Experts from...
Cell and Gene Therapy 03/04/2018 The UK is a Leader in Preclinical Cell and Gene Therapy Research The UK has a rich and diverse range of preclinical research and is setting the foundations for the therapies of the future. The...
Cell and Gene Therapy 21/03/2018 WEBINAR SERIES: Funding, Commercialisation and Market Access for... This webinar series has been co-organised by Phacilitate and Biotech and Money/LSX
Cell and Gene Therapy 15/03/2018 Curing COGs with Automation Is automation the cure for the cost of goods pandemic?
Cell and Gene Therapy 07/03/2018 Increasing Access to Cell and Gene Therapies: The Potential of... Could outcome-based annuity payments, in which cell and gene therapies are paid for over-time as benefits materialise, increase...
Cell and Gene Therapy 05/03/2018 The ROI of Automation in Cell-based Therapy Bioprocessing and... Phacilitate and Biolacuna have produced a cutting-edge report, which includes the results, data and analysis of an industry-wide survey, plus...
Cell and Gene Therapy 19/02/2018 Part Five: Commercialisation The supply chain story concludes with a focus on commercialisation and scale-up
Cell and Gene Therapy 19/02/2018 Part Four: Cryopreservation This report provides a comprehensive guide to successfully investing in advanced therapies. It also outlines across six chapters each of the...
Cell and Gene Therapy 19/02/2018 Part Three: Transportation This five-part supply chain case study series continues with one of the transportation
Cell and Gene Therapy 19/02/2018 Part Two: Registration and Workflow Management The second step in the supply chain case study series is registration and workflow management
Cell and Gene Therapy 19/02/2018 Part One: Supply Chain Planning This five-part supply chain case study series begins with one of the most important factors in the success of your supply chain. Planning
